Total Payments
$3,852
2024 Payments
$250.86
Companies
35
Transactions
216
Medicare Patients
702
Medicare Billing
$108,691
Payment Breakdown by Category
Food & Beverage$3,692 (95.9%)
Consulting$150.00 (3.9%)
Education$9.81 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,692 | 213 | 95.9% |
| Consulting Fee | $150.00 | 1 | 3.9% |
| Education | $9.81 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $445.92 | 42 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $396.93 | 17 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $257.12 | 21 | $0 (2024) |
| PFIZER INC. | $241.34 | 14 | $0 (2024) |
| Orexo US, Inc. | $224.64 | 8 | $0 (2020) |
| GlaxoSmithKline, LLC. | $206.06 | 11 | $0 (2024) |
| ABBVIE INC. | $186.20 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $156.20 | 11 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $153.46 | 10 | $0 (2020) |
| Lilly USA, LLC | $150.28 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $250.86 | 10 | ABBVIE INC. ($111.22) |
| 2023 | $243.51 | 9 | Janssen Pharmaceuticals, Inc ($180.44) |
| 2022 | $233.40 | 7 | Abbott Laboratories ($100.00) |
| 2021 | $305.31 | 18 | AbbVie Inc. ($58.49) |
| 2020 | $512.83 | 28 | PFIZER INC. ($115.16) |
| 2019 | $944.88 | 52 | Orexo US, Inc. ($148.36) |
| 2018 | $596.19 | 44 | Sunovion Pharmaceuticals Inc. ($122.90) |
| 2017 | $764.59 | 48 | Alkermes, Inc. ($150.00) |
All Payment Transactions
216 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Gastroenterology | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Neuroscience | ||||||
| 01/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: VACCINES | ||||||
| 01/26/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $39.18 | General |
| Category: Neuroscience | ||||||
| 11/08/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Neuroscience | ||||||
| 10/05/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: VACCINES | ||||||
| 10/04/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Neuroscience | ||||||
| 07/07/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: Neuroscience | ||||||
| 05/31/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Neuroscience | ||||||
| 05/31/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Gastroenterology | ||||||
| 04/26/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $39.84 | General |
| Category: Neuroscience | ||||||
| 03/02/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Neuroscience | ||||||
| 11/09/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Neuroscience | ||||||
| 07/27/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: PRIMARY CARE | ||||||
| 07/20/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: Neuroscience | ||||||
| 04/19/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: Neuroscience | ||||||
| 03/14/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Heart Failure | ||||||
| 03/03/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 65 | 164 | $28,520 | $14,182 |
| 2022 | 4 | 108 | 237 | $39,970 | $18,480 |
| 2021 | 6 | 168 | 367 | $56,970 | $27,102 |
| 2020 | 13 | 361 | 739 | $110,815 | $48,927 |
Total Patients
702
Total Services
1,507
Medicare Billing
$108,691
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 139 | $25,020 | $12,390 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 25 | $3,500 | $1,792 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 182 | $32,760 | $14,966 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 32 | $4,480 | $1,767 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $2,310 | $1,512 | 65.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $420.00 | $235.04 | 56.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 157 | $28,260 | $13,980 | 49.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 89 | $12,460 | $6,034 | 48.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $4,200 | $2,783 | 66.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 15 | 59 | $5,900 | $2,020 | 34.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,250 | $1,377 | 42.4% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 14 | 29 | $2,900 | $908.91 | 31.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 99 | 295 | $53,100 | $21,712 | 40.9% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 21 | 166 | $16,600 | $5,755 | 34.7% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 20 | 21 | $5,840 | $4,314 | 73.9% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 33 | 37 | $6,290 | $3,774 | 60.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 30 | 30 | $6,300 | $3,669 | 58.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 48 | $6,720 | $2,737 | 40.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $5,500 | $2,661 | 48.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 21 | 21 | $3,150 | $1,866 | 59.2% |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 fo | Office | 2020 | 17 | 39 | $4,000 | $1,224 | 30.6% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 15 | 15 | $1,500 | $436.79 | 29.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 19 | 19 | $665.00 | $367.64 | 55.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 15 | 15 | $600.00 | $268.29 | 44.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 11 | 11 | $550.00 | $143.43 | 26.1% |
About Dr. Alok Krishna, MD
Dr. Alok Krishna, MD is a Addiction (Substance Use Disorder) healthcare provider based in Folsom, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437100898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alok Krishna, MD has received a total of $3,852 in payments from pharmaceutical and medical device companies, with $250.86 received in 2024. These payments were reported across 216 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,692).
As a Medicare-enrolled provider, Krishna has provided services to 702 Medicare beneficiaries, totaling 1,507 services with total Medicare billing of $108,691. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction (Substance Use Disorder)
- Other Specialties Family Medicine
- Location Folsom, CA
- Active Since 05/12/2006
- Last Updated 03/07/2023
- Taxonomy Code 101YA0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437100898
Products in Payments
- LATUDA (Drug) $443.23
- SPRAVATO (Drug) $320.52
- XIFAXAN (Drug) $262.02
- Zubsolv (Drug) $224.64
- VRAYLAR (Drug) $157.37
- REXULTI (Drug) $156.20
- SilverHawk (Device) $132.26
- TRELEGY ELLIPTA (Drug) $130.84
- JANUVIA (Drug) $107.36
- CHANTIX (Drug) $103.07
- CARDIOMEMS (Device) $100.00
- BEVESPI AEROSPHERE (Drug) $85.03
- Lucemyra/Lofexidine (Drug) $74.90
- JARDIANCE (Drug) $73.68
- Dynasplint (Device) $71.59
- EMGALITY (Drug) $70.18
- NURTEC ODT (Drug) $69.88
- SOLIQUA (Drug) $68.82
- XARELTO (Drug) $62.89
- UBRELVY (Drug) $52.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Addiction (Substance Use Disorder) Doctors in Folsom
Dr. Michael Millman, Ph.d, PH.D
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Mr. Leonardo Martinez, Lcsw, Cadcii, LCSW, CADCII
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Deana Long, Ba, Cadc Ii, Icadc, BA, CADC II, ICADC
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Casey Moore, Acsw, ACSW
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Mrs. Yvonne Thomas, Ms, Cadc-Iii, MS, CADC-III
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Stephanie Trumm, Rn, Carn, Laadc, RN, CARN, LAADC
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)